Jafron Biomedical Co.,Ltd.

SZSE:300529.SZ

20.36 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 700.066738.982732.67436.366473.838439.586572.558465.738471.416856.93697.355893.649593.55609.353578.901635.448445.658490.793378.882460.547312.425363.678295.17318.404241.822249.728206.554226.7163.323180.504147.964170.14113.598134.307125.596163.883123.161119.679102.183
Cost of Revenue 119.228150.545158.65896.63390.48884.755112.108101.50586.707143.83108.064133.92993.1289.49485.521102.27260.45771.1954.04361.15341.71451.20143.32748.33535.12539.28131.734.5826.35227.42725.56928.44818.19220.42520.27525.15419.7318.4115.331
Gross Profit 580.838588.437574.013339.733383.35354.831460.45364.233384.709713.1589.292759.72500.43519.86493.38533.175385.201419.603324.839399.394270.711312.477251.843270.069206.698210.447174.855192.12136.971153.077122.395141.69295.406113.882105.32138.729103.431101.26986.852
Gross Profit Ratio 0.830.7960.7830.7790.8090.8070.8040.7820.8160.8320.8450.850.8430.8530.8520.8390.8640.8550.8570.8670.8660.8590.8530.8480.8550.8430.8470.8470.8390.8480.8270.8330.840.8480.8390.8470.840.8460.85
Reseach & Development Expenses 61.93147.85154.17269.02261.73760.59654.02491.62462.46159.05140.77277.66444.9430.26220.90532.4317.43418.71912.17621.0917.47916.55113.33214.70711.55810.8758.9989.3837.00210.246021.77208.69020.51202.7182.718
General & Administrative Expenses 116.377-26.13938.47-64.201101.515-16.47827.613-59.52480.064-17.2929.109-49.5466.278-12.78227.192-50.16225.507-13.28723.408-41.89724.651-11.91922.309-35.6821.027-19.18928.231-42.99621.651-7.77815.739-31.31517.6316.93912.976-22.75414.46312.2469.222
Selling & Marketing Expenses 320.277182.267158.498174.922117.471166.645156.936238.973157.287179.948124.425232.485146.71106.264113.03168.908128.523102.38668.621167.29698.79690.57769.217121.62367.79662.7847.14676.4850.10645.82237.25147.09533.34534.77535.27444.52436.50131.2424.91
SG&A 436.653227.77198.244110.721218.986150.166184.549179.449237.351162.658153.535182.946212.98893.481140.221118.746154.0389.09992.029125.4123.44778.65791.52685.94388.82343.59175.37633.48571.75838.04452.9915.78150.97551.71448.24921.7750.96343.48634.132
Other Expenses -229.595-7.949-8.782-6.559-5.781-2.959-2.32290.046-52.67116.0786.164-5.314-3.253-1.896-0.244-9.191-0.639-1.328-11.246-5.957-1.1980.049-1.942-15.285-2.17914.406-0.113-3.4870.1699.5452.22.8751.52.6891.8234.6751.680.6990.761
Operating Expenses 268.989275.621252.415296.496215.012267.447236.252361.119247.142237.788200.47365.209222.039137.773166.072244.557171.369126.214106.745231.424144.51112.832107.575152.966102.07295.3577.655110.54675.01468.79355.86872.21152.3853.97550.52167.55553.23445.66936.006
Operating Income 307.378312.816321.59728.69175.606100.344239.1797.863141.535486.288393.768403.953282.601396.652334.719302.969221.296302.698227.389183.832134.516207.569154.413125.285115.771127.894107.35899.92465.33797.35169.09973.40244.78461.08754.49573.27250.657.62150.547
Operating Income Ratio 0.4390.4230.4390.0660.3710.2280.4180.0170.30.5670.5650.4520.4760.6510.5780.4770.4970.6170.60.3990.4310.5710.5230.3930.4790.5120.520.4410.40.5390.4670.4310.3940.4550.4340.4470.4110.4810.495
Total Other Income Expenses Net -13.0117.50218.337-6.559-5.781-2.959-7.501-7.024-2.752-2.26-0.611-5.3140.95612.6697.1675.166.8267.979-1.9519.9047.1187.9738.204-7.1038.96627.20310.04615.1393.48322.4134.7625.7453.1793.8451.4796.7682.0722.720.448
Income Before Tax 294.367320.318339.93422.131169.82597.385231.6790.839138.782484.029393.157398.639279.347394.756334.475293.778220.657301.369216.143177.874133.318207.618152.471110113.591142.3107.24596.71365.439106.69771.28875.22646.20463.75256.27877.94252.26958.31951.293
Income Before Tax Ratio 0.420.4330.4640.0510.3580.2220.4050.0020.2940.5650.5640.4460.4710.6480.5780.4620.4950.6140.570.3860.4270.5710.5170.3450.470.570.5190.4270.4010.5910.4820.4420.4070.4750.4480.4760.4240.4870.502
Income Tax Expense 56.29653.49156.00616.84424.59117.43336.428-10.97615.68772.41158.76764.86336.33558.48851.69146.49834.21545.94332.29525.87521.69131.91723.10514.72917.76722.36317.33315.70411.00717.31711.65712.3437.47810.1379.38312.8488.64616.02213.467
Net Income 239.128267.74284.76612.837146.14780.979196.5311.815125.294412.949335.207333.728242.945336.835283.306247.83186.781256.204184.425152.91112.151176.177129.58496.0895.947119.97689.97780.95854.44489.3859.63162.88338.72753.61446.89565.09443.62242.29737.826
Net Income Ratio 0.3420.3620.3890.0290.3080.1840.3430.0250.2660.4820.4810.3730.4090.5530.4890.390.4190.5220.4870.3320.3590.4840.4390.3020.3970.480.4360.3570.3330.4950.4030.370.3410.3990.3730.3970.3540.3530.37
EPS 0.30.350.360.020.190.10.250.0150.160.510.420.420.30.420.350.310.230.320.230.190.140.220.160.120.120.150.120.10.0680.110.0740.0830.0530.0780.0680.0930.0620.0590.053
EPS Diluted 0.290.330.350.050.180.10.240.0150.150.510.410.420.30.420.350.310.230.320.230.190.140.220.160.120.120.150.120.10.0680.110.0740.0830.0530.0780.0680.0930.0620.0590.053
EBITDA 309.753346.359355.27157.769186.553106.608237.65718.182144.129491.436402.81401.586285.786402.561331.708274.089219.425303.761218.592201.291124.933218.052145.041157.096104.727152.11698.06881.99461.68284.23966.50385.5542.60260.20159.39671.16350.18957.58252.895
EBITDA Ratio 0.4420.4690.4850.1320.3940.2430.4150.0390.3060.5730.5780.4490.4810.6610.5730.4310.4920.6190.5770.4370.40.60.4910.4930.4330.6090.4750.3620.3780.4670.4490.5030.3750.4480.4730.4340.4080.4810.518